MCL Archives

MCL

Accelerated approval for a new mantle cell lymphoma drug

November 22, 2019

The Food and Drug Administration (FDA) has recently granted accelerated approval to BeiGene’s mantle cell lymphoma (MCL) oral therapy, zanubritinib (BRUKINSA). (more…)

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey

MCL

Accelerated approval for a new mantle cell lymphoma drug

Reader Survey

Test Your Knowledge

Wegovy TYK

About

Contact

Podcasts

American Nurse Journal

Accelerated approval for a new mantle cell lymphoma drug

MCL

Accelerated approval for a new mantle cell lymphoma drug

Reader Survey

Test Your Knowledge

Wegovy TYK

NurseLine Newsletter

About

Contact

Podcasts

<img class="rss-widget-icon" style="border:0" width="14" height="14" src="https://www.myamericannurse.com/wp-includes/images/rss.png" alt="RSS" /> American Nurse Journal

Accelerated approval for a new mantle cell lymphoma drug

American Nurse Journal